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Abstract 
 
Polysaccharides are suitable for application as hydrophilic matrices because of their ability to 
hydrate and swell upon contact with fluids, forming a gel layer which controls drug release. 
When extracted from plants, polysaccharides often contain significant quantities of starch that 5 
impacts upon their functional properties. This study aimed to evaluate differences in swelling, 
erosion and drug release from matrix tablets prepared from grewia gum (GG) and starch-free 
grewia gum (GDS) extracted from the stems of Grewia mollis. HPMC was used as a control 
polymer with theophylline as a model drug. Swelling, erosion, and in-vitro release were 
performed in deionized water, pH1.2 and pH6.8 media. The Vergnaud and Krosmeyer-10 
Peppas model were used for swelling and drug release kinetics, respectively. However, linear 
regression technique was used to determine the erosion rate. GDS compacts were 
significantly harder than the native GG and HPMC compacts. GDS matrices exhibited the 
fastest erosion and drug release in deionised water and phosphate buffer compared with the 
GG and HPMC. At pH1.2, GDS exhibited greater swelling than erosion, and drug release was 15 
similar to GG and HPMC. This highlights the potential of GDS as a matrix for controlled 
release similar to HPMC and GG at pH1.2 but with a more rapid release at pH6.8. GDS may 
have wider application in reinforcing compacts with relatively low mechanical strength. 
Keywords: HPMC K4M, grewia gum, starch-free grewia gum, matrix tablets, theophylline 
Abbreviations: HPMC, Hydroxypropyl methylcellulose; GG, native grewia gum; GDS, 20 
starch-free grewia gum; GGp, native grewia gum polymer; GDSp,  de-starched grewia gum 
polymer; HPMCp, hydroxypropyl methylcellulose polymer; HPMCf, hydroxypropyl 
methylcellulose formulation; GGf, native grewia gum formulation; GDSf, de-starched grewia 
gum formulation; HCl, hydrochloric acid; MDT, mean dissolution time; MDR, mean 
dissolution rate; DE, dissolution efficiency; DSC, differential scanning calorimetry;  USP, 25 
United States Pharmacopeia 
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1. Introduction  
In the developing world, the pharmaceutical sector depends heavily on petrochemicals due to 40 
majority of excipients being imported. Consequently, this accounts for high prices that are 
beyond the reach of the majority of the local populations, despite the fact that the countries of 
the developing world are often rich in renewable sources of raw materials suitable for use in 
the industry. Such materials which are abundant in nature and, can also be cultivated, remain 
largely undeveloped. Plant polysaccharides are one particular resource that could be used as 45 
alternative excipients and have come under increasing research focus in the design of dosage 
forms for oral controlled release administration (Naggar et al., 1992; Bonferoni et al., 1993; 
Kristmundsdo´ ttir et al., 1995; Sujja-areevath et al., 1996; Talukdar et al., 1996; Khullar et 
al., 1998; Vervoort et al., 1998; Munday and Cox, 2000; Mughal et al., 2011; Nep 2015). 
These materials are hydrophilic in nature and when in contact with water they hydrate and 50 
swell. This property has been utilized in the formulation of dosage forms (Nakano and Ogata, 
1984) where the powdered drug is embedded within the matrix of hydrophilic polymeric 
materials and compressed to produce matrix tablets. The release of drug from such 
hydrophilic matrices is described as a complex interaction between swelling, diffusion and 
erosion (Harland et al., 1988; Peppas and Sahlin, 1989; Colombo et al., 1990; Lee and Kim, 55 
1991; Colombo et al., 1992; Colombo et al., 1995; Reynolds et al., 1998; Munday and Cox, 
2000; Ghori et al., 2014a). 
Swelling is the result of the gradual imbibing of water to form an increasingly hydrated gel 
layer which is the diffusional path length across which the pharmaceutical active is 
transported via mechanisms of diffusion and gel layer dissolution (Wan et al., 1991; 60 
Panomsuket al., 1996). For polysaccharide matrices, this process has been shown to follow 
square root of time kinetics (Munday and Cox, 2000; Kavanagh and Corrigan, 2004).  
However, at the interface between the gel layer and the surrounding medium, other 
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mechanisms, in addition to diffusion, also come into play during drug release from matrices. 
The polymer chains gradually disentangle from the interface by erosion, thus enhancing drug 65 
release. Erosion of the polymer has also been shown to follow cube root of time kinetics 
(Munday and Cox, 2000; Kavanagh and Corrigan, 2004).   
Hydroxypropyl methylcellulose (HPMC) is the most widely used of the cellulosic 
controlled release agents, providing outstanding controlled release performance. It is a 
hydrophilic cellulose derivative that is non-ionic, with versatile matrix forming ability and is 70 
used to control the release of soluble and insoluble drugs. The different viscosity grades 
available afford the choice of material forming more or less viscous gels. Furthermore, the 
non-ionic nature of the material enables pH –independent release of drug from tablet matrices 
(Merchant et al., 2006; Sahoo et al., 2008; Mughal et al., 2011).  
Grewia mollis is a shrub which grows wild or cultivated in the middle belt region of 75 
Nigeria (and other parts of sub-saharan Africa) where the inner bark from the stems of the 
shrub is pulverised and used as a thickener in various food formulations. The native gum 
extract has previously been identified to contain polysaccharides (Okafor, Chukwu & Udeala, 
2001; Nep and Conway, 2011a) and has been evaluated as a pharmaceutical excipient in oral 
formulations, as a binder or sustained release matrix (Nep & Conway 2011b), as bioadhesive 80 
(Nep & Okafor 2006; Nep & Conway 2011c) or as a suspending agent (Nep & Conway 
2011d).  
Various extraction methods have been explored and shown to impact the functional 
properties of grewia gum extracts (Ogaji, 2011; Akdowa et al 2014). Furthermore, it has been 
reported that the native grewia gum (GG) contains a significant quantity of starch and the 85 
enzymatic removal results in a starch free material which differs from the native 
polysaccharide in the relative proportion of  monosaccharides and physicochemical properties 
(Nep et al., 2015). Consequently, it is anticipated that the starch-free grewia polysaccharide 
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(GDS) may exhibit different functional properties as compared with the native 
polysaccharide, thus providing the potential to diversify the applications using extracts 90 
produced using different methods. 
In the present study, matrix tablets of the starch-free grewia gum were compared with 
similar formulations of the native grewia gum to show the effect of starch digestion on the 
functional application in matrix tablet formulations.  
 95 
2. Materials and Methods 
2.1 Materials 
 Methocel (HPMC K4M) was a kind gift from Colorcon (UK) and was used as 
supplied from manufacturer. Lactose monohydrate (FlowLac
®
 100) was a kind gift from 
Meggle (Germany). Magnesium stearate was used as procured from Merck (Germany). 100 
Anhydrous theophylline (TCI Chemicals, Europe) was used as the model drug. Dissolution 
media were prepared according to the USP 2003 method using the following materials: 
potassium chloride (Acros Organics, UK) and hydrochloric acid (Fisher Scientific, UK) for 
pH 1.2, and potassium phosphate monobasic-white crystals (Fisher BioReagents, UK) and 
sodium hydroxide (Fisher Scientific, UK) for pH 6.8 media. Native grewia polysaccharide 105 
and starch-free grewia polysaccharide were extracted in our laboratory as previously reported 
(Nep et al., 2015).  
 
2.2 Extraction of native grewia polysaccharide (GG) and starch free grewia 
polysaccharide (GDS) 110 
The method of Nep et al., (2015) was adopted without modification. Briefly, the inner 
stem bark of Grewia mollis was dried and shredded. The material was then macerated in 
0.1% sodium metabisulphite for 24 hours. The swollen gum was separated from the residue 
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by filtration through a muslin bag and the filtrate was precipitated from solution using 
absolute ethanol. Further purification was achieved by re-dispersion in water and final 115 
precipitation in absolute ethanol to give the gum fraction code named GGp which was then 
oven dried at 50 °C for 24 hours. The dried GGp was milled to a particle size of 200 µm 
undersize using a centrifugal mill (ZM 100, Retsch Germany) set at a rotation speed of 
10,000 rpm equipped with a 200 m mesh filter. The milled powders were then collected and 
stored in sealed plastic containers before use in tablet formulation.  To obtain the starch-free 120 
grewia polysaccharide (GDSp), GGp was digested using 1 %w/v dispersion of GGp with 
Termamyl 120 L (1 %v/v) with stirring at 70 °C for 4 hours. Sample pH was adjusted to 4.5 
with 2 M HCl to precipitate the enzyme and the sample was then centrifuged at 4400 rpm for 
20 min. The supernatant was dialysed against deionized water for 72 hours using a cellulose 
membrane with molecular weight cut-off at 12500 Da. The material was then precipitated 125 
using 2 volumes of 95% ethanol followed by a solvent exchange using 1 volume of 95% 
propan-2-ol. The precipitate was oven dried overnight at 50 °C and subsequently, tested for 
starch using 1% v/v iodine in KI solution as described by Nep et al (2015). The starch-free 
grewia polysaccharide (GDSp) was size reduced to a particle size of 200 µm undersize and 
stored under the same conditions as the GGp.  130 
Particle size was determined using the Sympatec laser diffraction particle size 
analyser (Clausthal-Zellerfeld, Germany) according to the methodology detailed in Asare-
Addo et al., (2015). Chemical and physical characterisation of both GGp and GDSp batches 
used in this study are reported in Nep et al., (2015). 
2.3 Tablet formulation, compression, hardness and dimensions 135 
The pure polymers (GGp, GDSp and HPMC K4M) were compacted using a single 
punch tableting machine (Model MTCM-1, Globe Pharma US) at 6 different pressures (44.6, 
70.0, 97.4, 125.7, 150.8, and 176.0 MPa) to determine the effect of compression force on the 
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hardness of the pure polymer compacts and the tablet matrices. HPMC was used as a control 
due to its popular use in extended release matrices as a result of its robustness, stability, 140 
regulatory acceptance and cost effectiveness (Tiwari and Rajabi-Siahboomi, 2008; 
Nokhodchi and Asare-Addo, 2014). In the present study HPMC K4M was chosen as it is a 
mid-range viscosity grade (~4000 cp) and is commonly used in matrix tablets (Ghori et al., 
2014a). Tablets matrices, containing theophylline as a model drug, were formulated 
according to the unit formula in Table 1. Round convex tablets with a diameter of 10.0 mm 145 
and a target weight of 250 mg were prepared by blending the appropriate amounts of 
ingredients as shown in Table 1 for 10 min in a Turbula
®
 (Type T2C, Switzerland) blender 
and tablets formed by compression at 125.7 MPa. The compressed tablets were allowed to 
recover for 24 h,  the hardness of the tablets was determined on a hardness tester 
(PharmaTest, Germany) while the thickness and diameter of the matrix tablets was measured 150 
using a digital calliper (Toolzone, UK) .  
 
2.4 Bulk, tapped density and porosity of polymers and formulation blends  
The bulk and tapped densities of the pure polymers and formulation blends were 
determined by weighing 10 g of the material into a 100 mL measuring cylinder and, without 155 
disturbing the cylinder the volume was read to give the bulk volume of the powder. The 
measuring cylinder was than tapped until the volume of powder was constant. This represents 
the tapped volume of the polysaccharide gum powder. The bulk or tapped density was 
calculated as the ratio of the weight of powder to the bulk or tapped volume respectively. 
Porosity was determined according to equation 1.  160 
 
                [  [
            
             ⁄
                      
]]        (1) 
2.5 True density of the polymers and formulation blends  
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The true density of the polymers and formulation blends was determined using 
Micromeritics Accupyc II pycnometer 100 (Micromeritics, USA). The test was carried out 165 
using a multi-run system (10 runs) with a standard deviation of 0.005%. The results are the 
mean and standard deviation of three determinations.  
2.6 In-vitro release studies 
An automated USP dissolution apparatus II (paddle method) was used to monitor the 
dissolution profiles of theophylline from the tablet matrices. The dissolution medium was 900 170 
mL of deionized water, 0.1 N HCl (pH 1.2) or phosphate buffer (pH 6.8) equilibrated to 37 ± 
0.5 °C with a paddle stirring speed of 100 rpm. Samples were withdrawn at selected time 
intervals from 5 min up to 720 min using a peristaltic pump and the absorbance measured 
using a UV spectrophotometer. The concentrations of theophylline in the samples was 
determined using the linear regression equation obtained from the respective UV standard 175 
calibration curve at 272 nm.  
2.7 Dissolution parameters (dissolution efficiency (DE) and mean dissolution time 
(MDT)) 
The mean dissolution time (MDT), the mean time for the drug to dissolve under in-
vitro dissolution conditions, is a model-independent method and is suitable for dosage forms 180 
having different mechanisms of drug release (Al-Hamidi et al., 2013; 2014; Mu et al., 2003; 
Khan, 1975). Also calculated was the dissolution efficiency (DE), which is the area under the 
dissolution curve up to a certain time t, expressed as a percentage of the area of a rectangle 
described by 100% dissolution in the same time t (Khan, 1975).  
    
∑       
 
   
∑    
 
   
         (2) 185 
Where j is the sample number, n is the number of dissolution sample times,    is the 
time at midpoint between    and      and      is the additional amount of drug dissolved 
between    and     . 
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             (3) 
Where y is the drug percent dissolved at time t 190 
2.8 Similarity factor 
Similarity between the drug release profiles was determined using similarity factor f2 
(Moore and Flanner, 1996; Polli et al., 2004; Asare-Addo et al. 2010).  
         {[  
 
 
∑   (     )
  
   ]
    
     }     (4) 
where n is the number of pull points for tested samples;    is the optional weight factor;    is 195 
the reference assay at time point t;    is the test assay at time point t. 
Similarity factor was calculated using the drug release profile of HPMC K4M 
matrices as the reference. f2 values ranging from 50-100 indicate similarity between the two 
profiles. The closer the f2 value is to 100, the more similar or identical the release profiles. 
Values of f2 less than 50 indicate dissimilarity between two dissolution profiles (Polli et al., 200 
1997; Pillay and Fassihi, 1998).  
2.9 Kinetics of drug release  
The kinetics of drug release were analysed using the Korsmeyer-Peppas model Eq (5) 
as detailed in Siepmann & Peppas, (2001a) where, Mt/M
∞
 is the fraction of drug released at 
time t while K is a drug release constant incorporating the geometrical characteristics of 205 
matrix tablet, and n is diffusional exponent of drug release. For cylinders, i.e., the tablet 
matrices made in the present study, n values of up to 0.45 suggest Fickian diffusion, and 
values of above 0.89 suggest Case-II transport. A value between these two suggests 
anomalous transport occurring as reported in numerous studies (Siepmann and Peppas 2001b; 
Asare-Addo et al., 2013; Siahi-Shadbad et al., 2011; Ritger and Peppas 1987). 210 
 
  
  
                                                                                                          (5) 
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2.10 Swelling and erosion studies  
Swelling and erosion were determined according to a method described by Tahara et al. 215 
(1995). A USP II dissolution apparatus (PharmaTest, Germany) was used and set to 100 rpm 
and equilibrated at 37 °C. The deionized water, pH 6.8, or pH 1.2 buffer were used as 
swelling/erosion media. The matrix tablets were supported on pins at the bottom of the 
dissolution vessel. Swelling/erosion media (900 mL) was measured into each of the six 
vessels of the bath and allowed to equilibrate for 30 min before starting the experiment. The 220 
experiment consisted of allowing the tablets to swell and/or erode in the medium at 100 rpm 
for 30, 60, 120, 180 or 240 min before they were removed into a pre-weighed weighing boat. 
The excess dissolution medium was drained and blotted from around the tablet without 
disrupting the tablet. The tablet and weighing boat were then weighed to establish the wet 
weight of the tablet. The mean weight was determined for each formulation and degree of 225 
swelling (S) was calculated using Eq. (6): (Ghori et al., 2014b) 
                                                            
     
  
                      (6) 
Where Wi and Ws are initial dry and swollen weight of matrix tablet, respectively, at 
immersion time (t) in the swelling media. The degree of swelling was determined from the 
mean of three replicates and presented as degree of swelling (S, %) against time (t). Finally, 230 
the tablets were dried to a constant weight in an oven at 50 °C. The tablets were cooled to 
ambient temperature and then weighed until a constant weight had been achieved and this 
was termed as dried weight of matrix tablets. The degree of erosion (E) was calculated using 
Eq. (7) (Ghori et al., 2014a) 
                                                            
     
  
                      (7) 235 
Where, Wi is the initial weight of the matrix tablets and Wf is the weight of the dried 
matrices at specific sampling times. 
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The swelling kinetics of all the matrix tablets was determined by fitting the swelling 
data to a mathematical swelling model described by Vergnaud (1993). This model has been 
used by several authors to explain the mechanism of swelling (Ghori et al., 2014c, Chaibva et 240 
al., 2010, Roy and Rohera, 2002, Ebube et al. 1997) and the generalised form of Vergnaud 
model is shown in Eq. (8)  
                                                                               (8) 
Where,  
M = the amount of liquid transferred 245 
t = time 
K = the swelling constant.  
n = exponent indicating the mechanism of water uptake.  
 
Ebube et al. (1997) reported that a value of n < 0.5 is indicative of a diffusion-250 
controlled mechanism in which the rate of diffusion is much slower than the rate of polymer 
hydration in a matrix tablet. However, when n = 1, water diffuses through the matrix at a 
constant velocity, with an advancing liquid front marking the limit of liquid penetration into 
the matrix. A value of 0.45 < n < 1 indicates an anomalous behaviour in which diffusion of 
liquid and polymer hydration are of similar magnitude. Moreover, the authors showed that 255 
when a simple linear regression was applied to a plot of percentage matrix erosion vs time the 
slope represented erosion rate (k, % min
-1
) (Ghori et al., 2014a). 
2.12 Differential Scanning Calorimetry (DSC)  
Free and bound water of the tablets using endothermic scanning of the melted free 
water was performed as reported previously (Asare-Addo et al., 2011; Kaialy et al., 2013). 260 
Briefly, flat faced 4 mm disks with target weights of 20 mg were produced from all pure 
polymers and formulation blends and compressed using a single punch tableting machine (as 
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before) at 2500 psi (150.8 MPa). The discs were placed in standard aluminium pans (40 µL) 
containing 25 mg of purified water, 0.1N HCl (pH 1.2), or phosphate buffer (pH 6.8) and 
sealed with a lid. The pure polymers were then allowed to hydrate for up to 30 min to 265 
determine the influence of time on bound and free water states. The tablet formulations were 
hydrated for 5 min before DSC analysis. This was to determine if the state of water in the 
matrices could relate to the dissolution profiles of the tablets formulations. DSC analysis was 
performed in three stages. First, the samples were cooled from ambient temperatures (~25 
°
C) 
to -30 °C at a rate of 55 °C/min to freeze any unbound (free) water; secondly, sample was 270 
held at -30 °C for 5 minutes for equilibration and thirdly, sample was heated from -30 °C to 
50 °C at 10 °C/min. The experiment was run under nitrogen atmosphere and at a flow rate of 
50 cm
3
. These experiments were carried out in triplicate. 
 
3. Results and Discussion 275 
3.1 Physical properties of formulation blends  
Properties of the pure polymers and formulation blends or compacts are presented in 
Table 2. The results show that the bulk density of the pure polymers (GGp, GDSp and 
HPMCp) increased upon blending with other formulation ingredients.  The GDSp and the 
formulation blend (GDSf) exhibited the highest porosity of all the formulation blends and 280 
formed the hardest compacts or tablets at any given compression pressure (Figure 1). Thus 
GDSp is a highly compactible polymer, forming matrices with greater hardness compared 
with GGp or HPMCp matrices. What is interesting also is that the de-starching process did 
not affect the true density of the GDS polymer as its true density remained the same as the 
GG (Table 1). 285 
Particle size analysis showed the HPMC K4M to have a d10 value of 26.79 µm, d50 of 
78.67 µm and d90 of 141.63 µm. The results also showed d99 to have a value of 171.10 µm 
14 
 
 
 
3.2 Swelling and erosion of matrices 290 
           Upon its initial contact with liquid media the liquid starts to imbibe into the dry matrix 
tablet and the change in overall weight of matrix tablet is reflected as swelling. The extent of 
swelling was determined by using Eq. 6 and plotted with respect to time and shown in Figure 
2 (a-c). The matrix erosion, however, which is a fundamental property of matrix tablets 
which occurs when the polymer chains present on the surface disentangle and begin to 295 
dissolve. Eventually this leads to bulk surface dissolution of polymer chains which is widely 
considered as matrix erosion. In this study the degree of matrix erosion was calculated by 
using Eq. 7 and % erosion vs time was plotted (Figure 4 a-c).    
 
The results show that GGf matrices exhibited the highest extent of swelling in all media. 300 
GDSf matrices swell within the first 30 min in deionized water but are rapidly eroded 
thereafter (Figure 2A).  In pH 6.8 media, GDSf matrices were observed to swell rapidly in the 
first 30 min and thereafter plateau until 180 min when erosion of the tablets occurred (Figure 
2B). However, the least extent of swelling was exhibited by HPMC (K4M) matrices in pH 
1.2. Moreover, to study the mechanism of swelling Vergnaud model was used, Eq. 8 305 
(Vergnaud 1993) and swelling parameters were enlisted in Table 3. The model, however, was 
not applicable to GDSf as these particular matrices start to erode quickly. In general the R
2
 
values were in the range of 0.953-0.991, which indicate that the data can be well described by 
this model. According to the swelling kinetics findings, GGF has the highest swelling rate 
(Kw) 64.16 % min
-1
 in water but HPMCf has highest Kw 25.59 and 32.00 % min
-1
 in pH 6.8 310 
and pH 1.2 media, respectively.  All the grewia gum matrices, however, showed a no 
significant difference in pH 1.2 media which might be attributed to its anionic nature. The 
polymer swelling kinetics can also be inferred from the value of swelling exponent (n) 
15 
 
According to the criteria laid out by Ebube et al., (1997) all the matrix tablets apart from GGf 
in pH 6.8 showed diffusion controlled swelling, where the rate of polymer relaxation is 315 
greater than the rate of liquid penetration in to the polymer matrix network. However, GGf 
specifically in pH 6.8 swelling media showed an anomalous polymer swelling behaviour in 
which the rate of water diffusion and polymer relaxation is of same magnitude. Eventually 
after the swelling phase the hydrophilic polymer based matrices underwent erosion. The rate 
of polymer erosion was determined by using the data in Figure 4 and the erosion kinetics 320 
parameters were enlisted in Table 3. The R
2 
of erosion kinetics findings were in the range of 
0.954-0.998, and therefore attributed to a good fit indicating that the findings can explain the 
erosion phenomena. In water HPMCf showed highest erosion rate (KE  = 0.354 % min
-1
) 
while in pH 6.8 GDSf showed highest erosion (KE  = 0.297 % min
-1
). However, in pH 1.2 
media the matrices have not showed any substantial difference in the erosion rates. Hydration 325 
of polysaccharides matrices occurs when hydrogen-bonding forces maintain the integrity of 
the hydrophilic polysaccharide matrix during the course of the experiment (Munday and Cox, 
2000). Therefore, for any given material, when the hydrogen bonding forces are weak in any 
given media, matrix erosion may prevail.  This probably explains the relatively higher 
erosion rate of GDSf matrices in water and pH 6.8 in contrast to pH 1.2 (Figure 4). The GDSf 330 
matrices rapidly hydrate upon contact with water or pH 6.8 media but the gel layer formed 
was not durable or resistant to erosion at 100 rpm. 
Furthermore, the hydration rate of polysaccharides depends on the nature of the substituent 
groups and the degree of substitution (Roy and Rohera, 2002). HPMC K4M is a non-ionic 
polymer and has been reported (Streubel et al., 2000; Tatavarti and Hoag, 2006; Tatavarti et 335 
al., 2004; Gabr, 1992) to exhibit pH independent drug release as a result of pH independent 
swelling and erosion of the matrices when drug solubility is pH independent.  
 
16 
 
 Both GGp and GDSp have both been reported to be anionic polysaccharides (Nep et al., 
2015). Consequently, a pH dependent swelling and erosion of the matrices may be expected. 340 
However, the percentage content of uronic acids in GDSp (64 %w/w) is higher than GGp (58 
%w/w), and likewise GDSp has a greater degree of acetyl esterification (GDSp 49% and 
GGp 34%) (Nep et al., 2015). Sungthongjeen et al., (2004) has shown that the degree of 
esterification of pectins can modify drug release from pectin based matrices 
The decrease in erosion rate of GDSf matrices in pH 1.2 media may be attributable to a 345 
decrease in the ability of GDSp to hydrate as the pH falls below the pKa of the uronic acids 
present in the polymer chains.   
Images of matrices after 3 hours of swelling and erosion in the different media are shown in 
Figure 3, which clearly shows the relatively rapid erosion and dissolution of GDSf matrices 
in deionised water and pH 6.8 media as compared with GGf and HPMCf. 350 
 
 
3.4 Drug release from matrices 
The release profiles are presented in Figure 6. The dissolution parameters T50 and T100 
are shown in Table 4. The profiles show that none of the matrices exhibited any initial burst 355 
release of theophylline despite the propensity for initial burst release of soluble drugs from 
HPMC (Tiwari et al., 2003; Gohel et al., 2009; Huand and Brazel, 2001). Initial burst release 
is attributable to the rapid dissolution of the drug from the surface and near the surface of the 
matrix which occurs while the polymer is undergoing hydration to form a protective gel 
layer. 360 
The release of theophylline in deionized water was fastest from the GDSf matrices 
which released 100% of the drug within 120 min (Figure. 5A). This may be explained to be 
as a consequence of the excessive erosion and dissolution of the GDSf matrices in deionized 
water. Conversely, GGf matrices showed the slowest release of theophylline in deionized 
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water. Similarly, in pH 6.8 media, GDS matrices showed the fastest release of theophylline 365 
with 100% of drug released after 240 min (Figure. 5C), also attributable to excessive erosion 
of the matrices.   
However, in pH 1.2 media, it was observed that the extent and rate of drug release 
from the different polymer matrices were more or less the same (Figure. 5B) with GDSf 
matrices releasing 100% of drug only after 330 min. The present results show that GDSf 370 
matrices release 100% of the drug faster in pH 6.8 (240 min) than in pH 1.2 media (330 min) 
in contrast with HPMC K4M and GGf matrices. 
The release of the drug from the polymer matrices was also compared using 
dissolution efficiency (DE), mean dissolution time (MDT) and similarity factor (f2). The DE 
and MDT are presented in table 4. The results show that the DE for the matrices in pH 1.2 375 
media was 86.91%, 87.27% and 87.58% for GGf, GDSf and HPMC K4M  matrices 
respectively, and indicates that the efficiency of release of the drug from the matrices was 
essentially the same in this medium. This is also supported by the similarity factor (f2) for the 
matrices in pH 1.2 media (Table 4). The f2 was 83.66 and 82.15 for GGf and GDSf matrices 
respectively with HPMC K4M as the reference verifying GGf and GDSf’s similar drug 380 
release in pH 1.2 media to HPMC K4M. However, at pH 6.8, and in deionized water, there 
was a larger difference in release. The higher DE of GDSf (95.01% and 89.9% in water and 
pH 6.8 media respectively) concurs with the high erosion of the material in both media. 
Conversely the lower values of DE for GGf may be attributable to the swelling of the 
material which persisted over the duration of the release study.  385 
 
3.5 Modelling of drug release 
The release kinetics for the polymer matrices are presented in Table 4. The release of 
theophylline from HPMC K4M matrix tablets has been reported (Asare-Addo et al., 2011; 
18 
 
Sriamornsak et al., 2007) to fit well with both Higuchi equation and Korsmeyer–Peppas 390 
equation. The Higuchi model describes drug release that is largely governed by diffusion 
through water-filled pores in the matrices, while the Korsmeyer–Peppas model describes the 
combined effect of diffusion and erosion mechanisms for drug release (Korsmeyer et al., 
1983). 
Theophylline release from GDSf matrices in pH 1.2 and pH 6.8 media were typically 395 
non-Fickian with a best fit to Korsmeyer-Peppas model indicating that drug release was by a 
combination of diffusion and erosion. In deionized water the model could not be determined 
because there were insufficient data points on the release profiles between 10% and 60% 
release to provide accurate values. Similarly, the release was anomalous (non-Fickian) and 
diffusion controlled release for GGf and HPMC (K4M) matrices in deionized water, pH 1.2 400 
and pH 6.8 media. Interestingly, the release data of GDSf matrices fitted well with zero-order 
release model with a correlation coefficient (r
2
) greater than 0.996 (not shown) probably due 
to the extensive swelling of the tablets in deionized water as shown in Figure 2a.  
 
 405 
3.6 DSC hydration results and theophylline release from matrices 
Jhon and Andrade, 1973 classifies hydration water to three types, namely; Type I 
(freezing or free, bulk-like water) melts at the normal melting point of pure water (0 °C). 
Type II (freezing or bound water) weakly interacts with macromolecules and displays a lower 
melting point than pure water (<0 °C).  Type I and II can be classed as free or freezable water 410 
with type III being classed as bound water. Bound water has the ability to interact with the 
ionic and hydrophilic groups of polymers and shows non-freezing behaviour. Water 
penetrates into a tablet matrix during the first stages of dissolution and acts as bound water. 
Aoki et al., (1995) explained that during the next stages of dissolution, the water content of 
19 
 
the matrices increases and freezable water is detected at levels that are related to drug release. 415 
Figure 6 shows the percentage of bound water with increasing time (1, 5, 10, and 30 min) for 
the pure polymers in deionized water, calculated from the thermographs in Figure 7.  All the 
thermographs for the pure polymers demonstrated a slight shift to the left with an increase in 
hydration time. The results showed HPMC K4M to bind more to water as compared with 
GGp and GDSp. There was also an increase in the amount of bound water occurring with an 420 
increase in time. Due to the first time point of dissolution being at 5 min, hydration values to 
determine bound and free water states were utilised for the formulation matrices to establish a 
correlation between free water state and drug dissolution. This however was difficult to 
establish. The results however showed that GDSf, GGf and HPMC K4M  matrices bound to 
deionized water more than to the other two media used (Table 5). It can be seen that the 425 
amount of available water for hydration increased in pH1.2 or phosphate buffer (pH6.8) for 
all the matrices. Also, HPMC K4M generally binds more to water in all the tested media as 
compared with GGf and GDSf formulations. This was similar to the trend for the pure 
polymers. Interestingly, when comparing the amount of bound water at the same time point 
(5 min) for the pure polymer and formulation compact, it is observed that the incorporation of 430 
drug and the lactose significantly reduces the bound water percentage. 
 
4. Conclusion 
Starch-free grewia polysaccharide is a highly compressible and compactible polymer with 
superior compression and compaction properties to those of GG and HPMC (K4M). The 435 
results show that variations in release properties are also apparent, depending on the polymer 
and the dissolution media used.  In pH 1.2 media, drug release from GGS was similar to GG 
and HPMC (K4M) matrices and exhibited greater swelling than erosion. Rapid release of 
drug was observed from the GDS matrices in water and at pH6.8, mainly due to erosion. This 
20 
 
was despite forming compacts with greater hardness than GGp or HPMCp.  GG matrices on 440 
the other hand, slowed down drug release when compared with HPMC (K4M) attributable to 
the greater swelling of the material. Overall this study has demonstrated the potential of 
grewia gum as a matrix former that can modify the release of a water soluble drug as a 
potential alternative to HPMC. Furthermore, by using different grades of the raw material it is 
possible to achieve different types of drug release. In addition, the superior compaction 445 
properties of GDSp may provide a wider application as a binder to strengthen weak 
compacts.  
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Tables 
Table 1: Unit formula for matrix tablets by direct compression 
Table 1: Unit formula for matrix tablets by direct compression 715 
Formulation 
code 
Theophylline 
(mg) 
Native grewia 
gum (GG) 
(mg) 
De-starched 
grewia gum 
(GDS) (mg) 
HPMC 
K4M (mg) 
Lactose 
(mg) 
MgSt 
(mg) 
GG 125 75 - - 47.5 2.5 
GDS  125 - 75 - 47.5 2.5 
HPMC (K4M)  125 - - 75 47.5 2.5 
 
 
 
Table 2: Properties of the pure polymer, formulation mixes, polymer compacts and 
tablet matrices 720 
 
 True 
density 
(g/cm
3
) 
Bulk 
density 
(g/cm
3
) 
Tapped 
density 
(g/cm
3
) 
Tablet Porosity 
(%) at 13.79 
MPa 
Tablet hardness 
(N) at 13.79 
MPa 
GGp  1.59±0.00 0.37±0.01 0.81±0.03 52.08±1.92 81.75±5.40 
GGf 1.53±0.02 0.43±0.01 0.74±0.00 42.77±0.24 88.94±1.13 
GDSp 1.59±0.01 0.20±0.03 0.38±0.02 49.61±1.93 375.07±38.78 
GDSf 1.53±0.02 0.35±0.01 0.65±0.01 42.30±0.46 148.79±6.38 
HPMCp 1.36±0.03 0.31±0.01 0.46±0.04 40.91±2.47 146.17±5.46 
HPMCf 1.45±0.02 0.36±0.01 0.65±0.01 39.98±0.29 97.77±1.50 
Note: ―p‖ and ―f‖ next to GG, GDS or HPMC is for pure polymer and formulation blends 
respectively. 
 
 725 
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Table 3: Parameters for swelling and erosion kinetics 
 750 
 
 
Kw= Swelling constant (% min
-1
), n = Swelling exponent, KE= Erosion rate (% min
-1
) 
 
 755 
Table 4:  Dissolution parameters from release profiles of GG, GDS and HPMC K4M 
formulation tablet matrices 
 
Matrix Media 
 
T50 (min) 
 
T100 (min) 
DE (%) MDT 
Diffusional 
exponent, n 
Similarity 
factor (f2) 
GG water 120 540 80.98 136.96 0.43 37.96 
 
pH 1.2 67 330 86.91 94.22 0.45 83.66 
 
pH 6.8 97 720 80.52 140.28 0.46 52.86 
GDS water 32 120 95.01 35.91 N/A N/A 
 
pH 1.2 75 330 87.27 91.69 0.44 82.15 
 
pH 6.8 60 240 89.9 72.72 0.54 56.49 
HPMC water 60 270 88.65 81.72 0.47 - 
 
pH 1.2 60 330 87.58 89.41 0.46 - 
 
pH 6.8 70 360 86.45 97.57 0.49 - 
 
 760 
Table 5: Bound water (%) of the pure polymer compacts (HPMCp, GDSp, GGp) and 
the formulated tablet matrices (HPMCf. GDSf, GGf) in all media at 5 min 
 
Compact Water (%) pH 1.2 (%) pH 6.8 (%) 
GDSp 21.2±1.56 13.39±2.22 18.23±0.40 
GDSf 11.93±0.03 6.03±0.84 7.01±0.06 
GGp 24.84±1.59 17.34±0.80 17.87±0.12 
GGf 13.39±0.41 5.01±1.85 5.47±0.11 
HPMCp 27.43±0.88 18.46±0.18 22.22±0.42 
HPMCf 13.02±2.22 9.8±1.87 8.98±0.73 
 
Matrices 
Swelling kinetics parameters Erosion kinetics parameters 
n Kw R
2
 KE R
2
 
GGf-water 0.3461 64.16 0.977 0.1603 0.954 
GDSf-Water - - - 0.1548 0.991 
HPMCf-Water 0.2111 32.16 0.966 0.3546 0.957 
GGf-pH 6.8 0.4781 24.95 0.978 0.1409 0.981 
GDSf- pH 6.8 - -  0.2973 0.954 
HPMCf- pH 6.8 0.2334 25.59 0.953 0.1449 0.992 
GGf-pH 1.2 0.3979 19.51 0.991 0.1611 0.998 
GDSf- pH 1.2 0.3573 19.34 0.970 0.1812 0.979 
HPMCf- pH 1.2 0.2058 32.00 0.990 0.1704 0.997 
28 
 
Figures 765 
 
Figure 1: Dependence of hardness on compression pressure for the polymer compacts 
(HPMCp, GGp and GDSp) and formulation matrices (HPMCf, GGf and 
GDSf).  
 770 
 
 
Figure 2: Swelling of HPMCf, GGf and GDSf matrices in A) deionized water B) 
phosphate buffer (pH 6.8) and C) 0.1N HCl (pH 1.2) 
 775 
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Figure 3: Photographs of the swelling and erosion of formulation matrices in (a) 
phosphate buffer (pH 6.8) (b) 0.1N HCl (pH 1.2), and (c) deionized water at 780 
37
o
C for 3 hours 
 
 
 
 785 
Figure 4: Dissolution medium uptake per unit polymer remaining A. for formulation 
matrices in different media, B. for formulation matrices in different media, 
plotted versus t
0.5 
in water at 100 rpm. C. Dry weights of matrices in different 
media at 100 rpm fitted to cube root of time equation 
 790 
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Figure 5: Release profiles of theophylline in: A. deionized water B. 0.1N HCl (pH 1.2) 
and C. phosphate buffer (pH 6.8) equilibrated to 37 °C and agitation speed of 795 
100 rpm 
 
 
Figure 6: Representative bound water profiles of Pure Polymer compacts in distilled 
water 800 
31 
 
 
 
Figure 7: DSC Thermograms of the pure polymer compacts after hydration for 1, 5, 10, 
and 30 min in deionized water for A. GDS B. GG and, C. HPMC K4M 
